A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction-Reference-Cited by-同舟云学术

A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction

Published:2004-12 Issue:7 Volume:6 Page:927-935
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Abdulla Jawdat¹,Abildstrom Steen Z.²,Christensen Erik³,Kober Lars⁴,Torp-Pedersen Christian⁵

Affiliation:

1. Department of Cardiology P; Gentofte University Hospital; Niels Andersensvej 65, DK-2990 Hellerup Denmark

2. National Institute of Public Health; Denmark

3. Department of Medicine I; Bispebjerg University Hospital; Denmark

4. Rigshospitalet Heart Centre, Department of Medicine; Division of Cardiology B; Denmark

5. Department of Cardiology Y; Bispebjerg University Hospital; Copenhagen Denmark

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference62 articles.

1. Effect of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);The CONSENSUS Trial Study Group;N Engl J Med,1987

2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N Engl J Med,1991

3. On behalf of SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial;Pfeffer;N Engl J Med,1992

4. For the Trandoplapril Cardiac Evaluation (TRACE) Study Group. A clinical Trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction;Køber;N Engl J Med,1995

5. What is the ideal study design for evaluation of treatment for heart failure=;Narang;Eur Heart J,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-Month Enalapril Treatment in Pediatric Fontan Patients With Moderate to Good Systolic Ventricular Function;The American Journal of Cardiology;2022-01

2. Heart Failure: A Palliative Medicine Review of Disease, Therapies, and Medications With a Focus on Symptoms, Function, and Quality of Life;Journal of Pain and Symptom Management;2020-05

3. Sacubitril/Valsartan;Heart Failure Clinics;2018-10

4. Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure;The Lancet;2017-05

5. Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease;Current Hypertension Reports;2017-02